Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05849701
Other study ID # P.T/INTG/3/2023/45
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 10, 2022
Est. completion date April 15, 2023

Study information

Verified date May 2023
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be a randomized, open-label, pretest post-test with two study groups.


Description:

The randomization procedure will be performed by a simple drawing of lots (A or B) which determined whether participants would receive Shock wave therapy ( group A) or vacuum-assisted closure therapy (group B). Patients in both groups will receive the same medical treatment and nursing care.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date April 15, 2023
Est. primary completion date February 14, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 60 Years
Eligibility Inclusion Criteria: All patients had chronic diabetic foot ulcers that did not heal within six weeks of the incidence. Exclusion Criteria: Patients with acute cellulitis, osteomyelitis, or gangrene anywhere in the affected extremity. Patients with renal, hepatic, neurological, or malignant diseases. Patients with severe protein malnutrition (serum albumin < 2.0 g/dl) or severe anemia (Hgb < 7.0 g/dl). Patients with an ankle-brachial index < 0.7, absence of the dorsalis pedis or posterior tibial artery pulse. Patients who had debridement; pregnancy. Patients who refused to join the study, or to sign the written consent.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Shock wave therapy
using gymna Shock Master 500 with an input voltage of alternating current (AC) 220 Volte, 100 pulses at 0.13 m joule/mm at 3 Hz per session for 6 weeks.
Vacuum-assisted closure
Using KCI's Vacuum Assisted Closure Device for six weeks, the pump delivered an intermittent negative pressure of -125 mmHg. The cycle was of seven minutes during which the pump was on for five minutes and off for two minutes, the dressings were changed on the fourth day.

Locations

Country Name City State
Egypt Shaimaa Mohamed Ahmed El Sayeh Cairo

Sponsors (2)

Lead Sponsor Collaborator
Cairo University Kafrelsheikh University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Wound surface area using the ruler method to to measure the longest length and the widest width and multiplying them. change from baseline and after six weeks of intervention.
Primary Wound volume using the ruler method to to measure the longest length, the widest width and the deepest area multiplying them. change from baseline and after six weeks of intervention.
Secondary Wound surface area using the ruler method to to measure the longest length and the widest width and multiplying them. change from baseline and after two weeks of intervention.
Secondary Wound surface area using the ruler method to to measure the longest length and the widest width and multiplying them. change from baseline and after four weeks of intervention.
Secondary Wound volume using the ruler method to to measure the longest length, the widest width and the deepest area multiplying them. change from baseline and after two weeks of intervention.
Secondary Wound volume using the ruler method to to measure the longest length, the widest width and the deepest area multiplying them. change from baseline and after four weeks of intervention.
See also
  Status Clinical Trial Phase
Terminated NCT04838600 - A PMCF Investigation on Chronic LU and DFU in Need of Debridement With ChloraSolv®
Completed NCT00709514 - Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers Phase 2
Completed NCT05338463 - Fespixon Cream for the Treatment of Chronic Diabetic Foot Ulcers (TEXAS 1A, 2A) in Dialysis Patients Phase 4